GAVI to get GSK’s malaria vaccine from Bharat Biotech in 26.
• Bharat Biotech International to supply RTS.S, developed by GSK, to Gavi from 2026.
• Supplies part of Gavi’s next replenishment phase (Gavi 6.0, 2026-2030).
• Plans to reduce vaccine price by over half to less than $5 by 2028.
• RTS.S was recommended by WHO in 2021.